Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-02-20 @ 1:44 PM
Study NCT ID:
NCT03823092
Status:
UNKNOWN
Last Update Posted:
2019-01-30
First Post:
2019-01-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Polarization Perception in Health and Disease. Testing a New Sight Test
Sponsor:
South Warwickshire NHS Foundation Trust
Organization:
Study Overview
Official Title:
Polarization Perception in Health and Disease. Testing a New Sight Test: The TaNSiT Study
Status:
UNKNOWN
Status Verified Date:
2019-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TaNSiT
Brief Summary:
A study to assess the utility of human polarization pattern perception for the detection, diagnosis and monitoring of eye disease
Detailed Description:
The recently described high sensitivity of the human eye to differentiate small angular differences in linear polarization and evidence supporting its macular origin (Misson, Anderson; 2017) suggests that human polarization sensitivity might be a useful diagnostic tool for macular disease. This augments a previous study in which we demonstrated the ability of the human visual system to detect isochromatic isoluminant polarization modulated pattern stimuli (Misson et al 2015).
This is an exploratory 'proof-of-concept' study to determine the clinical value of polarization pattern perception, PPP, in health and disease. We further propose that PPP might be valuable for the diagnosis, monitoring and early detection of macular disease. The latter includes common blinding conditions such as age related macular degeneration and diabetic retinopathy. It is also intended to investigate the effect of cataracts and cataract surgery on PPP: cataract surgery modifies the optics of the eye so might also modify PPP.
PPP is measured using a modification of the methodology described in (Misson et al 2015) and (Misson, Anderson; 2017) whereby polarization modulated patterns are presented on a modified LCD display. The observer's task is to report if they see an image and to describe the image. Images comprise simple patterns or traditional optotypes. A standard set of images are presented in pseudorandom order and the response recorded. A total score, the polarization pattern perception score PPP is then determined from the number of images seen/identified. A more refined metric, the polarization visual acuity pVA, will be derived from the response to the optotype stimuli. These data are then compared to conventional tests of visual structure and function including logMAR visual acuity, ocular examination and OCT scan data.
The study in anticipated to comprise:
Phase 1. Normative Evaluation: observational prospective cross-sectional.. A preliminary normative study will be undertaken on staff members. The aim is to quantify normative values in preparation for the clinical studies.
Hypotheses to be tested:
1. that healthy subjects can perceive polarization stimuli
2. that there is a threshold of polarization image resolution (pVA) analogous to visual acuity. Normative PPP and pVA data will be collected.
Phase 2 Patient Group: observational Prospective cross-sectional / case-control.
Phase 2 subjects will comprise normals and patients with cataracts/pseudophakia and/or AMD, other macular pathology, diabetic retinopathy..
The aim of this phase is to determine the effect, if any, of particular eye conditions on pVA/PPP alone and in comparison with other test parameters.
Hypotheses to be tested:
1. that eye conditions affect pVA/PPP
2. that specific eye conditions have a selective effect on pVA/PPP
3. that pseudophakia affects pVA/PPP
Phase 3: Cataract pre-op v post op pVA/PPP: prospective interventional case-control.
Timescale:concurrent with Phase 2 A subset of the phase 2 cataract patients will undergo cataract surgery according to clinical need. These patients are routinely reviewed 4 - 8 weeks post-op when the opportunity will arise to repeat pVA/PPP measurement. The fellow eye will serve as a control / provide data for repeatability assessment.
The aims of this phase are
1. to determine the repeatability of pVA/PPP testing in a heterogeneous patient group
2. to determine the effect of cataract surgery on the pre-operative pVA/PPP results
3. to determine if pVA/PPP is a useful determinant of post-operative visual outcome.
Hypotheses:
1. that pVA/PPP testing is repeatable
2. that there is a difference in pVA/PPP pre and post cataract surgery
This is an exploratory 'proof-of-concept' study to determine the clinical value of polarization pattern perception, PPP, in health and disease. We further propose that PPP might be valuable for the diagnosis, monitoring and early detection of macular disease. The latter includes common blinding conditions such as age related macular degeneration and diabetic retinopathy. It is also intended to investigate the effect of cataracts and cataract surgery on PPP: cataract surgery modifies the optics of the eye so might also modify PPP.
PPP is measured using a modification of the methodology described in (Misson et al 2015) and (Misson, Anderson; 2017) whereby polarization modulated patterns are presented on a modified LCD display. The observer's task is to report if they see an image and to describe the image. Images comprise simple patterns or traditional optotypes. A standard set of images are presented in pseudorandom order and the response recorded. A total score, the polarization pattern perception score PPP is then determined from the number of images seen/identified. A more refined metric, the polarization visual acuity pVA, will be derived from the response to the optotype stimuli. These data are then compared to conventional tests of visual structure and function including logMAR visual acuity, ocular examination and OCT scan data.
The study in anticipated to comprise:
Phase 1. Normative Evaluation: observational prospective cross-sectional.. A preliminary normative study will be undertaken on staff members. The aim is to quantify normative values in preparation for the clinical studies.
Hypotheses to be tested:
1. that healthy subjects can perceive polarization stimuli
2. that there is a threshold of polarization image resolution (pVA) analogous to visual acuity. Normative PPP and pVA data will be collected.
Phase 2 Patient Group: observational Prospective cross-sectional / case-control.
Phase 2 subjects will comprise normals and patients with cataracts/pseudophakia and/or AMD, other macular pathology, diabetic retinopathy..
The aim of this phase is to determine the effect, if any, of particular eye conditions on pVA/PPP alone and in comparison with other test parameters.
Hypotheses to be tested:
1. that eye conditions affect pVA/PPP
2. that specific eye conditions have a selective effect on pVA/PPP
3. that pseudophakia affects pVA/PPP
Phase 3: Cataract pre-op v post op pVA/PPP: prospective interventional case-control.
Timescale:concurrent with Phase 2 A subset of the phase 2 cataract patients will undergo cataract surgery according to clinical need. These patients are routinely reviewed 4 - 8 weeks post-op when the opportunity will arise to repeat pVA/PPP measurement. The fellow eye will serve as a control / provide data for repeatability assessment.
The aims of this phase are
1. to determine the repeatability of pVA/PPP testing in a heterogeneous patient group
2. to determine the effect of cataract surgery on the pre-operative pVA/PPP results
3. to determine if pVA/PPP is a useful determinant of post-operative visual outcome.
Hypotheses:
1. that pVA/PPP testing is repeatable
2. that there is a difference in pVA/PPP pre and post cataract surgery
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: